SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-1315 Capital II, L.P.(68%),1315 Capital Management II, LLC(68%)
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ampersand 2018 Limited Partnership(76%),AMP-18 Management Company Limited Partnership(76%), etc.
D: Filing D
4: Statement of changes in beneficial ownership of securities-10% Owner 1315 Capital II, L.P.
4: Statement of changes in beneficial ownership of securities-10% Owner Ampersand 2018 Limited Partnership
Interpace Biosciences Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Douglas M. Singer(5.78%)
Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Christopher
Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer McCarthy Christopher
Interpace Biosciences Inc | 3: Initial statement of beneficial ownership of securities-Officer McCarthy Christopher
Interpace Biosciences Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Douglas M. Singer(8.32%)
Interpace Biosciences Inc | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter H. Kamin(18.6%)
Interpace Biosciences Inc | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter H. Kamin(18.6%)
Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities
Interpace Biosciences Inc | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities
Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities
Interpace Biosciences Inc | 3: Initial statement of beneficial ownership of securities
Interpace Biosciences Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Interpace Biosciences Inc | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities